Bone Turnover Markers and Prostate Cancer: Not Just a Measure of Bone Disease?

Affiliations

¹ Garvan Institute of Medical Research, Darlinghurst, Australia; St Vincent's Clinical School, Faculty of Medicine, UNSW Australia, Sydney, Australia. Electronic address: p.croucher@garvan.org.au.
² Department of Biochemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia.
³ Department of Surgery, University of Melbourne, Royal Melbourne Hospital, Melbourne, Australia.
⁴ Garvan Institute of Medical Research, Darlinghurst, Australia; St Vincent's Clinical School, Faculty of Medicine, UNSW Australia, Sydney, Australia.

Editorial

Peter I Croucher et al. Eur Urol. 2015 Jul.

. 2015 Jul;68(1):51-2.

doi: 10.1016/j.eururo.2014.10.041. Epub 2014 Nov 11.

¹ Garvan Institute of Medical Research, Darlinghurst, Australia; St Vincent's Clinical School, Faculty of Medicine, UNSW Australia, Sydney, Australia. Electronic address: p.croucher@garvan.org.au.
² Department of Biochemistry, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Australia.
³ Department of Surgery, University of Melbourne, Royal Melbourne Hospital, Melbourne, Australia.
⁴ Garvan Institute of Medical Research, Darlinghurst, Australia; St Vincent's Clinical School, Faculty of Medicine, UNSW Australia, Sydney, Australia.

No abstract available

Comment on

Bone-related Parameters are the Main Prognostic Factors for Overall Survival in Men with Bone Metastases from Castration-resistant Prostate Cancer.
Fizazi K, Massard C, Smith M, Rader M, Brown J, Milecki P, Shore N, Oudard S, Karsh L, Carducci M, Damião R, Wang H, Ying W, Goessl C. Fizazi K, et al. Eur Urol. 2015 Jul;68(1):42-50. doi: 10.1016/j.eururo.2014.10.001. Epub 2014 Oct 29. Eur Urol. 2015. PMID: 25449207 Clinical Trial.